Obinutuzumab

Obinutuzumab is a prescription injection used to treat chronic lymphocytic leukaemia (CLL) and follicular lymphoma. It is specifically designed to target and destroy certain abnormal white blood cells in the body, helping to manage these types of blood cancers.

This medicine is injected slowly into a vein by a healthcare professional in scheduled treatment cycles. It is not taken daily, and your schedule must be followed precisely to ensure the treatment works effectively. Since it is given as an injection, food intake does not affect how it is absorbed, but staying well-hydrated by drinking plenty of water before and after your sessions can help protect your kidneys.

While receiving this medicine, you may experience temporary reactions during the injection, such as fever, chills, or low blood pressure. Other common issues include low blood cell counts, which can increase your risk of infections. You must contact your doctor immediately if you experience severe shivering, breathing difficulties, or signs of a serious infection like a high fever.

Do not take this if you have had a severe, life-threatening allergic reaction to this medicine in the past. Before starting treatment, tell your doctor if you have a history of hepatitis B, kidney problems, or active infections, as this medicine can cause infections that were previously controlled by your immune system to become active again or worsen.

This medicine can interact with other drugs that weaken your immune system or live vaccines, which can lead to severe infections. If you are pregnant or breastfeeding, speak with your healthcare provider, as this medicine can cause harm to an unborn baby or nursing infant. Elderly individuals should also consult their doctor closely, as they may be more sensitive to side effects like infections.

Obinutuzumab helps target and destroy abnormal B-cells, supporting the treatment of certain blood cancers and helping improve disease control. The key benefits of Obinutuzumab are as follows:

• Targeted Cancer Cell Destruction: By directly seeking out and attaching to abnormal white blood cells, Obinutuzumab helps clear these cells from your bloodstream and lymph nodes.
• Long-term Disease Control: When combined with chemotherapy, it helps delay the progression of lymphoma and leukaemia, helping you maintain remission for a longer period.
• Customised Therapy Cycles: It is given in structured cycles, allowing your body time to recover and rebuild healthy cells between treatment sessions.

• Follow your doctor's instructions on the dosage and timing of this medication.
• A trained healthcare professional will administer Obinutuzumab.
• Do not self-administer.

Common Side Effects (Usually mild):

• Fever and chills
• Tiredness or weakness
• Mild diarrhoea or upset stomach
• Joint or muscle pain
• Cough or nasal congestion
   

Serious Side Effects (Consult your doctor right away):

• Severe infusion reactions (shortness of breath, chest tightness, throat swelling, or severe dizziness)
• Signs of infection (high fever, severe chills, painful urination, or a persistent cough)
• Signs of liver damage (yellowing of the eyes or skin, dark urine, or severe right-sided stomach pain)
• Signs of rapid cell breakdown, also known as tumour lysis syndrome—which happens when many cancer cells die quickly and release substances into the blood that can overwhelm the kidneys and heart (rapid heart rate, muscle cramping, or decreased urination)
• Signs of Progressive Multifocal Leukoencephalopathy (PML), a rare but dangerous brain infection caused by a virus that can become active when the immune system is very weak (confusion, loss of balance, vision changes, or difficulty speaking)